STRUCTURE/FUNCTION ANALYSIS OF ACAT
ACAT的结构/功能分析
基本信息
- 批准号:6721391
- 负责人:
- 金额:$ 35.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-04-01 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
Acyl coenzyme A:cholesterol acyltransferase (ACAT) utilizes two Iipophilic substrates, long-chain fatty acyl coenzyme A and cholesterol, to catalyze the formation of a neutral lipid cholesteryl ester (CE). At the single cell level, ACAT controls the cellular membrane cholesterol level by converting excess cholesterol into CEs. In cells involved in lipoprotein assembly, ACAT supplies CEs as part of the neutral lipid core in lipoproteins. Under pathophysiological conditions, ACAT is involved in forming CE-rich foam cells in the atherosclerotic plaques. The long-term goal of the PI of this application is to gain understanding of how this enzyme works at the molecular level. ACAT is a membrane bound enzyme located in the endoplasmic reticulum in minute quantity. The Pl's laboratory identified the first ACAT gene (human ACAT1) by functional complementation. The cloned human ACAT1 expressed in CHO cells and in insect cells has been solubilized by detergent and purified to homogeneity. At present, human ACAT1 is the only member of the membrane bound acyltransferase superfamily (comprised of at least 20 in numbers) that has been purified to homogeneity. The purified enzyme is shown to be under allosteric control by cholesterol. The enzyme is a homotetramer with multiple transmembrane domains. With various molecular reagents now available, in the current proposal, we request funds to test two hypotheses: A. Catalysis of ACAT1 may be completed within the plane of the ER membrane. B. ACAT1 may contain an allosteric sterol activator site in addition to a sterol substrate site. We enlist 3 Specific Aims: 1. To biochemically characterize the fatty acyI-CoA hydrolase activity intrinsically associated with hACAT1. 2. To probe the environment of the hydrophobic peptides (a.a. 446-468) comprising the putative ACAT active site. 3. To test the two sterol binding domain hypothesis.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ta Yuan CHANG其他文献
Ta Yuan CHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ta Yuan CHANG', 18)}}的其他基金
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage
通过阻断胆固醇储存来缓解 ADRD 中的溶酶体脂质缺陷
- 批准号:
9977871 - 财政年份:2018
- 资助金额:
$ 35.55万 - 项目类别:
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage
通过阻断胆固醇储存来缓解 ADRD 中的溶酶体脂质缺陷
- 批准号:
9789810 - 财政年份:2018
- 资助金额:
$ 35.55万 - 项目类别:
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage
通过阻断胆固醇储存来缓解 ADRD 中的溶酶体脂质缺陷
- 批准号:
10202476 - 财政年份:2018
- 资助金额:
$ 35.55万 - 项目类别:
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage
通过阻断胆固醇储存来缓解 ADRD 中的溶酶体脂质缺陷
- 批准号:
10187943 - 财政年份:2018
- 资助金额:
$ 35.55万 - 项目类别:
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage
通过阻断胆固醇储存来缓解 ADRD 中的溶酶体脂质缺陷
- 批准号:
9933635 - 财政年份:2018
- 资助金额:
$ 35.55万 - 项目类别:
Rescuing the ApoE4 genotype by activating sterol biosynthesis in the CNS
通过激活中枢神经系统中的甾醇生物合成来拯救 ApoE4 基因型
- 批准号:
9360281 - 财政年份:2017
- 资助金额:
$ 35.55万 - 项目类别:
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease
阿尔茨海默病中的胆固醇和鞘脂代谢
- 批准号:
9132655 - 财政年份:2010
- 资助金额:
$ 35.55万 - 项目类别:
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease
阿尔茨海默病中的胆固醇和鞘脂代谢
- 批准号:
8699618 - 财政年份:2010
- 资助金额:
$ 35.55万 - 项目类别:
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease
阿尔茨海默病中的胆固醇和鞘脂代谢
- 批准号:
9272296 - 财政年份:2010
- 资助金额:
$ 35.55万 - 项目类别:
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease
阿尔茨海默病中的胆固醇和鞘脂代谢
- 批准号:
8510542 - 财政年份:2010
- 资助金额:
$ 35.55万 - 项目类别:
相似海外基金
Discovery and development of selectivity-defined inhibitors toward two acyl-CoA : cholesterol acyltransferase isozymes
发现和开发两种酰基辅酶A的选择性抑制剂:胆固醇酰基转移酶同工酶
- 批准号:
18390008 - 财政年份:2006
- 资助金额:
$ 35.55万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impaired Acyl-CoA Synthetase-Muscle Lipid Oxidation in African American Women
非裔美国女性酰基辅酶 A 合成酶肌肉脂质氧化受损
- 批准号:
7289706 - 财政年份:2006
- 资助金额:
$ 35.55万 - 项目类别:
Impaired Acyl-CoA Synthetase-Muscle Lipid Oxidation in African American Women
非裔美国女性酰基辅酶 A 合成酶肌肉脂质氧化受损
- 批准号:
7664461 - 财政年份:2006
- 资助金额:
$ 35.55万 - 项目类别:
Novel physiological roles of acyl-CoA : lysophosphatidic acid acyItransferases.
酰基辅酶A的新生理作用:溶血磷脂酸酰基转移酶。
- 批准号:
18590073 - 财政年份:2006
- 资助金额:
$ 35.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Biochemical and pathological research of acyl-CoA : lysophosphatidic acid acyltransferases.
酰基辅酶A的生化和病理学研究:溶血磷脂酸酰基转移酶。
- 批准号:
16590062 - 财政年份:2004
- 资助金额:
$ 35.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Acyl-CoA Synthetase: Structure, Function and Regulation
酰基辅酶 A 合成酶:结构、功能和调节
- 批准号:
8370569 - 财政年份:2002
- 资助金额:
$ 35.55万 - 项目类别:
Acyl-CoA Synthetase: Structure, Function and Regulation
酰基辅酶 A 合成酶:结构、功能和调节
- 批准号:
6852639 - 财政年份:2002
- 资助金额:
$ 35.55万 - 项目类别:
Acyl-CoA Synthetase: Structure, Function and Regulation
酰基辅酶 A 合成酶:结构、功能和调节
- 批准号:
8850425 - 财政年份:2002
- 资助金额:
$ 35.55万 - 项目类别:
Acyl-CoA Synthetase: Structure, Function and Regulation
酰基辅酶 A 合成酶:结构、功能和调节
- 批准号:
8474746 - 财政年份:2002
- 资助金额:
$ 35.55万 - 项目类别:
Acyl-CoA Synthetase: Structure, Function and Regulation
酰基辅酶 A 合成酶:结构、功能和调节
- 批准号:
8667422 - 财政年份:2002
- 资助金额:
$ 35.55万 - 项目类别:














{{item.name}}会员




